World Pharma News Digest - 26.05.2014
4 views
Skip to first unread message
Ruslan David
May 26, 2014, 5:16:22 AM5/26/14
to worldph...@googlegroups.com
Scientists discover potential new target for cancer immunotherapy
Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments, according to a paper published online by Nature Medicine.
Read more...
http://www.worldpharmanews.com/research/2783-scientists-discover-potential-new-target-for-cancer-immunotherapy
Clinical trials designed to block autophagy in multiple cancers show promise
In the largest group of results to date, researchers from Penn Medicine's Abramson Cancer Center and other institutions have shown in clinical trials that the malaria drug hydroxychloroquine (HCQ) blocked autophagy in a host of aggressive cancers - glioblastoma, melanoma, lymphoma and myeloma, renal and colon cancers - and in some cases helped stabilize disease.
Read more...
http://www.worldpharmanews.com/research/2782-clinical-trials-designed-to-block-autophagy-in-multiple-cancers-show-promise
Screen of existing drugs finds compounds active against MERS coronavirus
Clinicians treating patients suffering from Middle East respiratory syndrome (MERS) currently have no drugs specifically targeted to the MERS coronavirus (MERS-CoV), a virus first detected in humans in 2012 that has since caused 614 laboratory-confirmed infections, including 181 that were fatal, according to the World Health Organization. The case count escalated sharply in the spring of this year, and the first cases in the United States were announced in early May.
Read more...
http://www.worldpharmanews.com/research/2781-screen-of-existing-drugs-finds-compounds-active-against-mers-coronavirus
Clarification regarding Pfizer statement
AstraZeneca PLC ("AstraZeneca") notes the announcement made by Pfizer Inc. ("Pfizer") dated 19 May 2014 seeking to clarify certain matters set out in its announcement on 18 May 2014 which set out its final proposal to AstraZeneca (the "Final Proposal Announcement"). Following some questions from shareholders, AstraZeneca wishes to make clear the following points:
Read more...
http://www.worldpharmanews.com/astrazeneca/2780-clarification-regarding-pfizer-statement
Study finds outcome data in clinical trials reported inadequately, inconsistently
There is increasing public pressure to report the results of all clinical trials to eliminate publication bias and improve public access. However, investigators using the World Health Organization's International Clinical Trials Registry Platform (ICTRP) to build a database of clinical trials involving chronic pain have encountered several challenges.
Read more...
http://www.worldpharmanews.com/research/2779-study-finds-outcome-data-in-clinical-trials-reported-inadequately-inconsistently
AstraZeneca rejects final proposal from Pfizer
The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal to combine the two companies. Leif Johansson, Chairman of AstraZeneca mentioned that the final proposal is a minor improvement which continues to fall short of the Board's view of value and has been rejected.
Read more...
http://www.worldpharmanews.com/financial/2778-astrazeneca-rejects-final-proposal-from-pfizer
PharmaNews.eu / Latest News
Finnish researchers discovered a new anticancer compound using accelerated drug screening process
http://www.pharmanews.eu/research-and-development/1446-finnish-researchers-discovered-a-new-anticancer-compound-using-accelerated-drug-screening-process
Biovision presents its selection of 44 promising life sciences businesses and projects
http://www.pharmanews.eu/conferences-and-events/1445-biovision-presents-its-selection-of-44-promising-life-sciences-businesses-and-projects
AstraZeneca and MRC Laboratory of Molecular Biology to launch joint research fund
http://www.pharmanews.eu/astrazeneca/1444-astrazeneca-and-mrc-laboratory-of-molecular-biology-to-launch-joint-research-fund
Shark antibodies inspire optimization of human antibodies
http://www.pharmanews.eu/research-and-development/1442-shark-antibodies-inspire-optimization-of-human-antibodies
New agent may enhance effectiveness of radiotherapy
http://www.pharmanews.eu/research-and-development/1443-new-agent-may-enhance-effectiveness-of-radiotherapy
Atlas shows how genes affect our metabolism
http://www.pharmanews.eu/research-and-development/1440-atlas-shows-how-genes-affect-our-metabolism
CNIO team presents a new strategy to personalise cancer therapies
http://www.pharmanews.eu/research-and-development/1441-cnio-team-presents-a-new-strategy-to-personalise-cancer-therapies
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
Scientists have found a way to target elusive cells that suppress immune response, depleting them with peptides that spare other important cells and shrink tumors in preclinical experiments, according to a paper published online by Nature Medicine.
Read more...
http://www.worldpharmanews.com/research/2783-scientists-discover-potential-new-target-for-cancer-immunotherapy
Clinical trials designed to block autophagy in multiple cancers show promise
In the largest group of results to date, researchers from Penn Medicine's Abramson Cancer Center and other institutions have shown in clinical trials that the malaria drug hydroxychloroquine (HCQ) blocked autophagy in a host of aggressive cancers - glioblastoma, melanoma, lymphoma and myeloma, renal and colon cancers - and in some cases helped stabilize disease.
Read more...
http://www.worldpharmanews.com/research/2782-clinical-trials-designed-to-block-autophagy-in-multiple-cancers-show-promise
Screen of existing drugs finds compounds active against MERS coronavirus
Clinicians treating patients suffering from Middle East respiratory syndrome (MERS) currently have no drugs specifically targeted to the MERS coronavirus (MERS-CoV), a virus first detected in humans in 2012 that has since caused 614 laboratory-confirmed infections, including 181 that were fatal, according to the World Health Organization. The case count escalated sharply in the spring of this year, and the first cases in the United States were announced in early May.
Read more...
http://www.worldpharmanews.com/research/2781-screen-of-existing-drugs-finds-compounds-active-against-mers-coronavirus
Clarification regarding Pfizer statement
AstraZeneca PLC ("AstraZeneca") notes the announcement made by Pfizer Inc. ("Pfizer") dated 19 May 2014 seeking to clarify certain matters set out in its announcement on 18 May 2014 which set out its final proposal to AstraZeneca (the "Final Proposal Announcement"). Following some questions from shareholders, AstraZeneca wishes to make clear the following points:
Read more...
http://www.worldpharmanews.com/astrazeneca/2780-clarification-regarding-pfizer-statement
Study finds outcome data in clinical trials reported inadequately, inconsistently
There is increasing public pressure to report the results of all clinical trials to eliminate publication bias and improve public access. However, investigators using the World Health Organization's International Clinical Trials Registry Platform (ICTRP) to build a database of clinical trials involving chronic pain have encountered several challenges.
Read more...
http://www.worldpharmanews.com/research/2779-study-finds-outcome-data-in-clinical-trials-reported-inadequately-inconsistently
AstraZeneca rejects final proposal from Pfizer
The Board of AstraZeneca PLC notes the announcement by Pfizer Inc. of its final proposal to combine the two companies. Leif Johansson, Chairman of AstraZeneca mentioned that the final proposal is a minor improvement which continues to fall short of the Board's view of value and has been rejected.
Read more...
http://www.worldpharmanews.com/financial/2778-astrazeneca-rejects-final-proposal-from-pfizer
PharmaNews.eu / Latest News
Finnish researchers discovered a new anticancer compound using accelerated drug screening process
http://www.pharmanews.eu/research-and-development/1446-finnish-researchers-discovered-a-new-anticancer-compound-using-accelerated-drug-screening-process
Biovision presents its selection of 44 promising life sciences businesses and projects
http://www.pharmanews.eu/conferences-and-events/1445-biovision-presents-its-selection-of-44-promising-life-sciences-businesses-and-projects
AstraZeneca and MRC Laboratory of Molecular Biology to launch joint research fund
http://www.pharmanews.eu/astrazeneca/1444-astrazeneca-and-mrc-laboratory-of-molecular-biology-to-launch-joint-research-fund
Shark antibodies inspire optimization of human antibodies
http://www.pharmanews.eu/research-and-development/1442-shark-antibodies-inspire-optimization-of-human-antibodies
New agent may enhance effectiveness of radiotherapy
http://www.pharmanews.eu/research-and-development/1443-new-agent-may-enhance-effectiveness-of-radiotherapy
Atlas shows how genes affect our metabolism
http://www.pharmanews.eu/research-and-development/1440-atlas-shows-how-genes-affect-our-metabolism
CNIO team presents a new strategy to personalise cancer therapies
http://www.pharmanews.eu/research-and-development/1441-cnio-team-presents-a-new-strategy-to-personalise-cancer-therapies
With best regards,
Ruslan David
Administrator/Editor
DAVID eHealth & Pharma UG,
Saarland University, Starterzentrum, Building A1 1,
66123, Germany
eHealthNews.eu, http://www.ehealthnews.eu
eHealthServer.com, http://www.ehealthserver.com
eHealthServer.de, http://www.ehealthserver.de
World Pharma News, http://www.worldpharmanews.com
PharmaNews.eu, http://www.pharmanews.eu
PS: Be on top of World Pharma News. Advertise with us!
World Pharma News is the leader in coverage and distribution of the top pharma industry, research and conference news. World Pharma News is one of the most visited sites on the Internet for pharma decision-makers looking for the latest breaking news. Why not put this traffic to work for you? It costs only a fraction of other on-line publications with far fewer readers. For further information, please feel free to contact us: http://www.worldpharmanews.com/contact-us
Reply all
Reply to author
Forward
0 new messages